World's Best Scientists 2026 revealed!
Karl C. Podratz

Karl C. Podratz

D-Index & Metrics

Medicine

D-Index
92
Citations
24960
World Ranking
11461
National Ranking
5873

Overview

Karl C. Podratz is affiliated with the Mayo Clinic in the United States. Their research primarily spans the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with focused contributions in Obstetrics and Gynecology, Cancer Research, Reproductive Medicine, Molecular Biology, and Surgery.

The main topics of Karl C. Podratz's work include:

  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Cancer-related molecular mechanisms research
  • Cancer Genomics and Diagnostics
  • Genetic factors in colorectal cancer
  • Cervical Cancer and HPV Research
  • Gynecological conditions and treatments

Frequent publication venues for their work are:

  • Gynecologic Oncology
  • PLoS ONE
  • American Journal of Obstetrics and Gynecology
  • Frontiers in Oncology
  • International Journal of Gynecological Cancer

They have co-authored with several researchers frequently, including:

  • Jamie N. Bakkum-Gamez
  • Jesús González Bosquet
  • Sean C. Dowdy
  • Kevin C. Halling
  • Amy L. Weaver

A selection of recent papers authored or co-authored by Karl C. Podratz includes:

  • Risk assessment of endometrial cancer and endometrial intraepithelial neoplasia in women with abnormal bleeding and implications for clinical management algorithms, 2020, American Journal of Obstetrics and Gynecology
  • Detection of endometrial cancer using tampon-based collection and methylated DNA markers, 2023, Gynecologic Oncology
  • Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options, 2021, PLoS ONE
  • PP2A and E3 ubiquitin ligase deficiencies: Seminal biological drivers in endometrial cancer, 2021, Gynecologic Oncology
  • ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer, 2022, PLoS ONE

Karl C. Podratz's work integrates clinical and molecular research approaches, addressing diagnostic and therapeutic challenges in gynecological cancers. Their contributions reflect ongoing investigation into cancer biomarkers, treatment stratification, and management algorithms relevant to endometrial and ovarian cancers.

Best Publications

  • Activity of the Dual Kinase Inhibitor Lapatinib (GW572016) against HER-2-Overexpressing and Trastuzumab-Treated Breast Cancer Cells

    Gottfried E. Konecny;Mark D. Pegram;Natarajan Venkatesan;Richard Finn

  • Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging.

    Andrea Mariani;Sean C. Dowdy;William A. Cliby;Bobbie S. Gostout

  • Ovarian Cancer: Screening, Treatment, and Follow-up

    Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld

  • Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?

    Andrea Mariani;Maurice J. Webb;Gary L. Keeney;Michael G. Haddock

  • Aggressive surgical effort and improved survival in advanced-stage ovarian cancer

    Giovanni D. Aletti;Sean C. Dowdy;Bobbie S. Gostout;Monica B. Jones

  • Increased Risk for Cancer in Patients with the Peutz-Jeghers Syndrome

    Lisa A. Boardman;Stephen N. Thibodeau;Daniel J. Schaid;Noralane M. Lindor

  • Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer.

    Giovanni D. Aletti;Sean C. Dowdy;Karl C. Podratz;William A. Cliby

  • Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

    Gottfried E. Konecny;Chen Wang;Habib Hamidi;Boris Winterhoff

  • Phase I Trial of Intraperitoneal Administration of an Oncolytic Measles Virus Strain Engineered to Express Carcinoembryonic Antigen for Recurrent Ovarian Cancer

    Evanthia Galanis;Lynn C. Hartmann;William A. Cliby;Harry J. Long

  • Human Epithelial Ovarian Cancer Allelotype

    W. Cliby;S. Ritland;L. Hartmann;M. Dodson

  • Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: discrimination of benign from malignant disease.

    George D. Malkasian;Robert C. Knapp;Philip T. Lavin;Vincent R. Zurawski

  • Potential therapeutic role of para-aortic lymphadenectomy in node-positive endometrial cancer.

    Andrea Mariani;Maurice J. Webb;Laura Galli;Karl C. Podratz

  • HER‐2/neu expression: A major prognostic factor in endometrial cancer

    D.J. Hetzel;T.O. Wilson;G.L. Keeney;P.C. Roche

  • Carcinoma of the vulva: analysis of treatment and survival.

    Podratz Kc;Symmonds Re;Taylor Wf;Williams Tj

  • Identification of prognostic factors and risk groups in patients found to have nodal metastasis at the time of radical hysterectomy for early-stage squamous carcinoma of the cervix

    Ronald D. Alvarez;Seng-Jaw Soong;Walter K. Kinney;Gary C. Reid

  • Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer☆☆☆

    Sanjeev Kumar;Karl C. Podratz;Jamie N. Bakkum-Gamez;Sean C. Dowdy

  • Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1

    B.M. Ryan;G.E. Konecny;S. Kahlert;H.-J. Wang

  • Prospective assessment of survival, morbidity, and cost associated with lymphadenectomy in low-risk endometrial cancer.

    S.C. Dowdy;B.J. Borah;J.N. Bakkum-Gamez;A.L. Weaver

  • Identification of a low-risk subset of patients with stage IB invasive squamous cancer of the cervix possibly suited to less radical surgical treatment.

    Walter K. Kinney;David O. Hodge;Edward V. Egorshin;David J. Ballard

  • Preoperative evaluation of serum CA 125 levels in premenopausal and postmenopausal patients with pelvic masses: Discrimination of benign from malignant disease

    GD Malkasian;RC Knapp;PT Lavin;VR Zurawski

Frequent Co-Authors

Sean C. Dowdy
Sean C. Dowdy Mayo Clinic
Gary L. Keeney
Gary L. Keeney Mayo Clinic
William A. Cliby
William A. Cliby Mayo Clinic
Amy L. Weaver
Amy L. Weaver Mayo Clinic
Lynn C. Hartmann
Lynn C. Hartmann Mayo Clinic
Stephen S. Cha
Stephen S. Cha Mayo Clinic
Vera J. Suman
Vera J. Suman Mayo Clinic
Peter C. O'Brien
Peter C. O'Brien Mayo Clinic
Thomas J. Sebo
Thomas J. Sebo Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in alternative or accelerated routes in healthcare, online degree programs offer flexible options to advance your medical career. Programs such as the fastest online dnp programs enable registered nurses to achieve a Doctor of Nursing Practice in less time, accommodating busy schedules and career goals.

If you’re looking for even quicker advancement, consider a 1 year dnp program online, which can significantly shorten the path to leadership roles in nursing. For those just entering the nursing profession, a 9 month lpn program provides a fast-track entry into healthcare with foundational skills and clinical experience.

Mental health is another growing field, and students can pursue advanced roles through the fastest psychiatric nurse practitioner program to support community mental wellness. These online pathways make it possible to tailor your education for specialized, in-demand roles without sacrificing work or personal obligations.

Best Scientists Citing Karl C. Podratz

Trending Scientists

Recently Published Articles